NASDAQ:CRNX

Crinetics Pharmaceuticals Stock Forecast

etoro logo Buy CRNX
*Your capital is at risk
$43.52
+0.85 (+1.99%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CRNX
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Crinetics Pharmaceuticals Inc stock upgraded to Buy Candidate
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Nov 17, 2025

The Crinetics Pharmaceuticals Inc stock price gained 1.99% on the last trading day (Monday, 17th Nov 2025), rising from $42.67 to $43.52. During the last trading day the stock fluctuated 5.72% from a day low at $41.96 to a day high of $44.36. The price has risen in 6 of the last 10 days and is up by 1.56% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 576 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $87.06 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $41.40 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 37.78% during the next 3 months and, with a 90% probability hold a price between $57.04 and $74.79 at the end of this 3-month period.

CRNX Signals & Forecast

The Crinetics Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $42.12 and $42.59. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, September 26, 2025, and so far it has fallen -5.21%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock

Crinetics Pharmaceuticals Inc finds support from accumulated volume at $42.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.40 between high and low, or 5.72%. For the last week, the stock has had daily average volatility of 5.15%.

Our recommended stop-loss: $41.10 (-5.57%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 36 days ago.)

Trading Expectations (CRNX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Crinetics Pharmaceuticals Inc to open at $43.28, and during the day (based on 14 day Average True Range), to move between $42.45 and $44.59, which gives a possible trading interval of +/-$2.13 (+/-5.03%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 5.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $44.43 (2.09%) than the support at $42.50 (2.34%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Crinetics Pharmaceuticals Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Crinetics Pharmaceuticals Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.446 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $43.28 ( 0.550%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CRNX Performance

Trading levels for CRNX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 45.68 4.96%
R2 44.76 2.86%
R1 44.20 1.55%
Price 43.52
S1 42.36 -2.66%
S2 41.80 -3.96%
S3 40.88 -6.06%

Accumulated Volume Support & Resistance Levels

Level Price
R3 45.91 5.49%
R2 45.76 5.15%
R1 44.43 2.09%
Price 43.52
S1 42.50 -2.34%
S2 40.00 -8.09%
S3 33.91 -22.08%

FAQ

What is the symbol for Crinetics Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Crinetics Pharmaceuticals Inc is CRNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Crinetics Pharmaceuticals Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Crinetics Pharmaceuticals Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.

What's the current price of Crinetics Pharmaceuticals Inc Stock?
As of the end of day on the Nov 17, 2025, the price of an Crinetics Pharmaceuticals Inc (CRNX) share was $43.52.

What is the 52-week high and low for Crinetics Pharmaceuticals Inc Stock?
The 52-week high for Crinetics Pharmaceuticals Inc Stock is $60.34 and the 52-week low is $24.10.

What is the market capitalization of Crinetics Pharmaceuticals Inc Stock?
As of the Nov 17, 2025, the market capitalization of Crinetics Pharmaceuticals Inc is 4.13B.

When is the next earnings date for Crinetics Pharmaceuticals Inc?
The upcoming earnings date for Crinetics Pharmaceuticals Inc is Feb 26, 2026.
Click to get the best stock tips daily for free!
ABOUT CRINETICS PHARMACEUTICALS INC
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE